Document is current
Any future updates will be listed below
-
Authors
Campagna, Jesus
Chandra, Sujyoti
Teter, Bruce
Cohn, Whitaker
Pham, Johnny
Kim, Young-Sug
Jagodzinska, Barbara
Vadivel, Kanagasabai
Alam, Parvez
Bilousova, Tina
Young, Malaney
Elias, Chris
Marcucci, Juan
Flacau, Ilinca
Jackman, Ainsley
Padder, Samar
Wi, Dongwook
Zhu, Chunni
Spilman, Patricia
Jung, Michael E
Bredesen, Dale E
John, Varghese
-
Funding
Funding for this research was provided by:
National Institutes of Health (AG051386-01)
- License Information
-
More Information
Article History
Received: 11 October 2024
Accepted: 26 March 2025
First Online: 23 April 2025
Declarations
:
: The authors declare no competing interests.
: The data presented in manuscript are described in the patent application UCLA 2020 − 832 for the SirT1 enhancer series of compounds.
: All in vivo procedures were performed in accordance with protocols approved by the UCLA Institutional Animal Care and Use Committee (IACUC). All methods were carried out in under the approval, accordance and ARRIVE guidelines.
